Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
VERTEX PHARMACEUTICALS INC / MA market cap for the quarter ending 2026-07-31 was $120.91B, a 3.18% increase year-over-year.
VERTEX PHARMACEUTICALS INC / MA market cap for the quarter ending 2026-06-30 was $125.81B, a 10.24% increase year-over-year.
VERTEX PHARMACEUTICALS INC / MA market cap for the quarter ending 2026-04-30 was $108.45B, a 17.11% decline year-over-year.
VERTEX PHARMACEUTICALS INC / MA market cap for the quarter ending 2026-03-31 was $113.47B, a 8.92% decline year-over-year.
VERTEX PHARMACEUTICALS INC / MA market cap for fiscal 2026 was $120.91B.
VERTEX PHARMACEUTICALS INC / MA market cap for fiscal 2025 was $115.17B, a 11.31% increase from fiscal 2024.
VERTEX PHARMACEUTICALS INC / MA market cap for fiscal 2024 was $103.47B, a 1.32% decline from fiscal 2023.
VERTEX PHARMACEUTICALS INC / MA market cap for fiscal 2023 was $104.85B, a 41.27% increase from fiscal 2022.